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ABSTRACT 
Background: As general population is aging, surgery in elderly patients become a major 
public health issue. This basic question is especially true for liver resection (LR). The aim of 
this study was to evaluate the operative risks of LR in elderly.  
Method: Retrospective analysis of a large recent and monocentric database of LR 
performed between January 1, 2005 and May 31, 2011. Patients were categorized into 3 
groups (<60, 60 to 74 and ≥75 years old) to analyze postoperative outcomes as well as 1-
year mortality. Clinicopathological factors likely to influence outcomes were assessed by 
univariate and multivariable analysis.  
Results: 1001 consecutive LR were performed in 912 patients (mean age 62±13 years). 
The distribution of the LR was 372 (37.2%), 477 (47.6%) and 152 (15.2%) in patients<60 y, 
60 to 74 y and ≥75 y old, respectively. The overall morbidity and mortality rates were 33.3% 
and 2.5%, respectively. An age ≥75 years was independently associated with postoperative 
mortality (OR 4.75 (95%CI [1.5; 15.1]; p=0.008) and 1-year mortality OR 2.8 (95%CI [1.2; 
6.6]; p=0.015), while the rate of postoperative complications (p=0.216), even major 
complications (p=0.09), was not increased. The other independent risk factors of mortality 
were a cirrhotic liver (p=0.017), preoperative arterial chemoembolization (p=0.001), caval 
vein clamping (p=0.001) and intraoperative blood transfusion (p=0.044). 
Conclusion: Age beyond 75 years represent a risk factor of death after LR and should be 
avoided after chemoembolization or in cirrhotic patients. A specific assessment using 
geriatric indexes might be the key to success in this population. 
INTRODUCTION 
Liver resection (LR) is the most suitable curative treatment for multiple benign and malignant 
liver diseases. With recent advances in surgical techniques, perioperative management and 
postoperative care, LR has become increasingly common, and the risks associated with this 
major procedure have decreased. In Western countries, increased longevity leads to 
subsequent increasing indications for liver resection in elderly patients. 
Recently, an editorial in Lancet (1) emphasized the need to provide the same care to elderly 
patients and younger patients whenever possible. Many papers have reported the absence 
of differences between elderly and younger patients in terms of postoperative morbidity and 
mortality.(2;3)  
During the last decades, the definition of „elderly‟ has evolved. While patients aged less than 
60 yrs old are nowadays considered to be young, most of the studies dealing with the impact 
of age on postoperative outcome have focused on the 60-75 yrs interval. Geriatricians now 
consider 75 years to be the age over which elderly and geriatric management starts.(4) In 
this setting, the feasibility and benefits of LR in elderly patients remain unclear, due to small 
sample sizes and the wide period of analysis.  While some reports showed higher 
postoperative mortality and morbidity rates related to age (5;6), others were unable to 
demonstrate any increasing morbidity or mortality after LR related to aging,(7) especially 
when the indication of LR was colorectal  metastases(8) (CRM) or hepatocellular 
carcinoma(9). 
The aim of this study was to analyze the outcomes after LR including the 1-year mortality in 
a large recent and monocentric series of patients with a special focus on age. Secondary 
objectives were to identify predictors of postoperative mortality that may be corrected 
preoperatively to decrease the risks of postoperative complications after LR in elderly 
patients. 
PATIENTS AND METHODS 
Patients 
The study population included all of the consecutive liver resections (LR) without biliary 
anastomosis that were performed at a single tertiary referral center between January 2005 
and May 2011. The clinical data were retrospectively collected from a liver resection 
database and analyzed after Institutional Review Board approval was obtained. (Opinion n° 
12-60) 
 
Preoperative assessment, surgical procedure and perioperative care 
Before surgery, each patient was evaluated by a thoracoabdominopelvic computed 
tomography (CT) scan with intravenous contrast. A measure of the future liver remnant 
volume (LRV) was performed when required, and portal vein embolization was performed 
when the LRV/Total liver volume ratio was < 35%. For malignant diseases, patients were 
considered to be curable if the tumors could be resected with macroscopically negative 
surgical margins.  
All LR were performed as open or laparoscopic procedures by senior hepatic surgeons. 
Continuous or intermittent pedicle clamping (Pringle maneuver), or selective clamping of the 
pedicles for the segment to be resected, was performed in most cases. Two closed-suction 
drains were placed in the resection space and removed on the fifth post-operative day 
(POD) when drainage was minimal, serous and non-bilious. 
The resections were categorized according to the International Hepato-Pancreato-Biliary 
Association classification for liver resections ((IHPBA, Brisbane 2000) i.e. resection of (i) 
two or less, (ii) three and four or (iii) more than four segments were defined as (i) minor 
(including wedge resection) (ii) major or (iii) extended hepatectomies, respectively.(10)  
All patients received antibiotic prophylaxis. A daily subcutaneous injection of low-molecular-
weight heparin sodium was started as a prophylactic against deep venous thrombosis on 
POD 1. 
  
Collected data 
The preoperative data included general patient characteristics (age, sex and BMI score, 
cirrhosis), prior surgical history and primary tumor histopathology. 
The perioperative data consisted of the operation duration, pedicle clamping or selective 
clamping of the pedicles for vascular resection when needed, vena caval clamping, 
concomitant abdominal surgery, and transfusion needs.  
The postoperative data included the hospital length of stay (HLS), need for intensive care, 
reoperations, and rehospitalization. Liver failure was defined by the “50-50” syndrome on 
postoperative day 5 (including serum bilirubin >50 µmol/L and prothrombin time <50%).(11) 
Postoperative complications were assessed and classified according to the Clavien-Dindo 
classification system.(12) Major complications were categorized as grades III-V and were 
defined as morbidity requiring radiological or surgical intervention. Postoperative mortality 
was defined as death occurring during the initial hospital stay or within 30 days after surgery 
if the patient was discharged. The 1-year post-operative mortality was also assessed. 
 
Statistical analysis 
Statistical analyses were performed with SPSS Statistics 17.0 software for Windows (SPSS 
Inc., Chicago, IL).  
Data from the study population were described either by means and standard deviations or 
by absolute and relative frequencies, for quantitative and qualitative data, respectively. 
To determine the cut-off over which mortality (perioperative and 1-year) was increased, 
accuracy curves were realized. 
To evaluate the cut-off over which mortality and morbidity were increased, we pooled the 
patients in 3 groups: Less than 60 yrs, 60 to 74 yrs and 75 yrs old or older.  Patient 
characteristics, perioperative parameters and outcomes were compared between the 3 
groups. 
The Chi square test or the Fisher exact test were used to compare qualitative data and the 
Student‟s t-test was used to compare quantitative data between groups. 
The perioperative and 1-year mortality were studied according to the patient characteristics, 
including age before liver resection, and perioperative factors. A univariate analysis was 
performed with the Chi-square test or the Fisher exact test when necessary. Factors 
associated with death with a p value < 0.2 were tested in a multiple logistic regression model 
using the forward selection procedure and the Wald test to assess their independent 
correlation with mortality. 
RESULTS 
Demographic and operative data 
Between January 2005 and May 2011, 1001 consecutive liver resections were performed in 
912 patients (626 men and 286 women). The mean age at the time of resection was 62 ± 13 
years. Two, three, four, or five successive resections were performed in 70, 6, 1 and 1 
patients, respectively. Among the LR, 504 (50.3%) were performed for liver metastasis, 375 
(37.5%) and 122 (12.2%) for primary liver malignant tumor and benign lesion respectively. 
The indications for LR are reported in table 1. 
The demographic characteristics and operative data in the <60, 60 to 74 yrs, and ≥ 75 age 
groups are reported in Table 2. One hundred and fifty two patients were ≥ 75 yrs (15.2%); in 
this group, patients had a significantly lower BMI and cirrhotic livers were less frequent.  
Postoperative mortality (table 3) 
The overall postoperative mortality rate was 2.6 %. The distribution of mortality according to 
the 3 age groups is shown in Figure 1(A). The cutoff of age over which perioperative 
mortality was increased, was represented in figure 2. Among the 15 factors assessed by the 
univariate analysis, age ≥ 75 years (p=0,045), cirrhosis (p=0,008), preoperative 
chemotherapy (p=0,015), preoperative arterial chemoembolization (p<0,001), preoperative 
portal vein embolization (p=0,005), primary cancer (p=0,015), major hepatectomy (p=0,005), 
caval vein clamping (p=0,006) and intraoperative blood transfusion (p=0,013) were 
significantly related to postoperative mortality. On the multivariable analysis, intraoperative 
blood transfusion (OR=2.4; confidence interval (CI) 95% [1; 5.5]; p=0.044), cirrhotic liver 
(OR=3.3; CI 95% [1.2; 8.9]; p=0.017), age ≥ 75 yrs (odds ratio [OR] 4.75; [CI] 95% [1.5; 
15.1]; p=0.008), preoperative arterial chemoembolization (OR=5.5; CI 95% [2; 15.3]; 
p=0.001), and intraoperative caval vein clamping (OR=6.1; CI 95% [2.1; 17.5]; p=0.001) 
remained significant  independent risk factors for postoperative death. 
Postoperative complications (tables 4 and 5) 
The overall morbidity rate was 33.3%, without a significant difference between the 3 age 
groups (p=0,216). There was no significant difference between the 3 groups (p=0,269) in the 
postoperative complications according to the Clavien-Dindo classification (table 4). 
Except for the hospital stay (p=0,02), there were no significant differences between the three 
groups, regarding the type of complications (table 5).  
1-year mortality (table 6) 
The overall 1-year mortality rate was 5.5%. The distribution of 1-year mortality according to 
the 3 groups of age is shown in figure 1(B). In the univariate analysis, age ≥ 75 years 
(p=0.018), sex (male, p=0.012), cirrhosis (p<0.001), preoperative chemotherapy (p=0.024), 
preoperative arterial chemoembolization (p=0.004), portal vein embolization (p=0.01), 
primary cancer (p<0.001), major hepatectomy (p<0.001) and intraoperative blood transfusion 
(p=0.001) were significantly associated with an increased 1-year mortality. In the multivariate 
analysis, age ≥ 75 years (OR 2.8; CI 95% [1.2; 6.6]; p=0.015), cirrhosis (OR=2.6; CI 95% 
[1.2; 5.6]; p=0.013), preoperative arterial chemoembolization (OR=5.5; CI 95% [2; 15.3]; 
p=0.001), primary cancer (OR=2.3; CI 95% [1.1; 4.6]; p=0.026), major hepatectomy (OR=3; 
CI 95% [1.5; 6]; p=0.002) and intraoperative blood transfusion (OR=2.1; CI 95% [1.1; 3.8]; 
p=0.016) remained independent predictive factors of increased 1-year mortality. 
 
 
DISCUSSION 
The main endpoint of the study was to analyze the impact of age on morbidity and mortality 
after liver resection. The results showed that ≥ 75 years of age was associated with 
increased postoperative and 1-year mortality. Preoperative portal vein embolization, 
chemoembolization, cirrhotic liver, intraoperative blood transfusion and caval vein clamping 
were also independent predictive factors of increased postoperative and 1-year mortality. No 
difference was found regarding the postoperative mortality between patients < 60 years and 
those aged 60 to 74 years.  
Similarly, the present results show that an age over 75 years old was a predictive factor for a 
longer hospital stay, which is consistent with the results of Cho and colleagues.(13)  
Compared with most of the previous studies, this work included a large number of patients 
resected by expert senior surgeons in a tertiary referral center in a short and recent period. 
These results may be predictive of the reality of liver surgery in the near future. Indeed, in 
the beginning of the 21st century, there were approximately 600 million elderly people 
worldwide, which is three times more than 50 years ago. Within the same period, the elderly 
population has been aging, with an increasing rate of  people ≥ 80 years old.(14) Due to 
these changing demographics, the elderly now account for > 60% of all new cancer cases 
and > 70% of cancer deaths.(15) This trend implies an expansion of surgical indications for 
increasingly older patients. 
In spite of the improved outcomes observed at high volume centers due to the advances in 
surgical management and postoperative care, LR is still associated with an increased 
mortality in elderly. Our results are consistent with previously reported data showing that the 
mortality risk after liver resection increased from 2.9 to 6.7 times in patients aged less or 
more than 75 years, respectively (16).  The novelty of our results was based on a higher 
postoperative mortality rate while postoperative morbidity according to the Clavien-Dindo 
classification was similar. There was no difference in liver failure or other liver-specific 
complications, indicating that the livers of elderly patients can tolerate surgery as well as 
younger patients can, as previously described by Cook et al after resection of colorectal liver 
metastases.(17)  
These results go against the idea that success in LR is linked to liver regeneration (LRG). 
Indeed, in the elderly, it is established that LRG is impaired (18) and delayed.(19) During 
aging, the liver is subjected to physiological changes such as alterations in hepatocyte 
morphology(20) and lower blood flow(21). These factors can reduce the liver‟s tolerance to 
ischemic damage and can lead to an alteration of liver function during LR.  
The imbalance between increased mortality without increasing morbidity reflects the lower 
possibility of adaption and response to any stress and complications in this subpopulation of 
patients. Advanced age should not be regarded as an absolute contraindication to hepatic 
resection, but should encourage a careful selection of surgical candidates. This preoperative 
selection process should be based on the comorbidities and tumor type thorough 
preoperative evaluation and a close collaboration between the surgeon, anesthesiologists 
and geriatricians. 
According to our multivariate analysis, 4 other independent risk factors for postoperative 
mortality were statistically significant: preoperative cirrhosis, preoperative arterial 
chemoembolization, caval vein clamping and intraoperative blood transfusion. These results 
strongly suggest that LR should be avoided in elderly patients with cirrhosis and therefore 
could be discussed for HCC. Nevertheless, Yamada et al (22)  reported the short and long-
term safety of LR for HCC in super-elderly patients, even those > 80 years old.(2;3;23) 
These results might be explained in part by the small sample size (n=11) for the super-
elderly group as well as selection bias. No patient in the Yamada study had an American 
Society of Anesthesiologists-Physical Status (ASA-PS) score ≥ 2. Recently, Ide et al. also 
emphasized that the mortality rate was similar in young (<75 years) and elderly (>75 years) 
patients with HCC.(24) They demonstrated that only surgical stress-preoperative risk score 
(PRS) was linked to postoperative morbidity in elderly.  
Referring to our results, LR appears to be safe as long as the liver is non-cirrhotic, a 
situation that is associated with benign tumors or colorectal liver metastases 
(CRLM).(17;25;26) Regarding the latest indication, the largest series currently published (25) 
reported 37.8% morbidity and 5% mortality rates, which are percentages that are 
comparable to our results.  
Furthermore, the results showed that intraoperative blood transfusion was associated with 
increased postoperative mortality. These results are in line with the findings of Shiba et 
al.(27) Patients who received blood transfusion during LR were more likely to have a longer 
postoperative length of stay and Clavien Grade IIIa or more complications.(28) These data 
emphasize the need to minimize bleeding during LR, which may be facilitated by the 
management of this condition at a referral center. 
The difficulty in gerontosurgery is linked to the evaluation of the physiological status of 
patients. Aging leads to reduced renal, hepatic, cardiopulmonary functional reserve and 
nutritional status. The ASA score is widely and often exclusively used, but has proven not to 
be sensitive enough for elderly patients undergoing major surgery.(29;30) More specific 
scores should be used in the elderly to better select patients before LR. Using surgery 
geriatric indices  such as the Charlson score (31;32), Cumulative Illness Rating Scale, or 
Kaplan-Feinstein index (33) might lead to better appraisal  of the physiological age. These 
geriatric indices have proven to be simple, reliable, and sensitive. Unfortunately, these 
factors could not be assessed in this retrospective study. Indeed, as comorbidities were not 
available in our liver resection database for the entire population, they could not be 
analyzed. This lack of data requires us to interpret our results with caution. Besides, this 
limitation is also encountered in other large retrospective study previously published on the 
same topic.(25) 
 
In summary, from this large series of LR at one tertiary referral center of liver surgery, we 
have identified the cut-off age that is closely correlated with an increased risk of mortality. An 
age over 75 years was independently associated with increased postoperative and 1-year 
mortality while postoperative morbidity, especially major complications, was not affected. 
These results may be explained by the loss of responsiveness to stress and complications 
related to age. A careful selection of elderly patients undergoing LR, avoiding patients with 
cirrhosis, and a specific assessment of the patient‟s general condition using geriatric indexes 
might be the key to success in this population. 
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FIGURE LEGEND 
Figure 1. The impact of age on mortality. (A) perioperative mortality and (B) 1-year 
mortality. 
Figure 2. Accuracy curve showing impact of age in mortality 
 
Table 1.  The indications for liver resections according to the patient age 
 
 
   Age (years) 
 < 60 60 to 74 >75 
 n=372 (%) n=477 (%) n=152 (%) 
Liver metastases 200 (53.8) 237 (49.7) 67 (44.1) 
Primary tumors 75 (20.1) 205 (43) 64 (42.1) 
Benign tumor 97 (26.1) 35 (7.3) 21 (13.8) 
 
Table 2 . The demographic characteristics and surgical data according to the patient age. 
 Parameter                    Age (years)   
  
< 60  
(n=372) 
60 to 74 
(n=477) 
>75 
(n=152) 
p value 
  
    
Gender 
male 59.1% 75.9% 66.4% 
<0.001 
female 40.9% 24.1% 33.6% 
      
      
BMI  
<25 46.2% 26.2% 33.6% 
<0.001 25 to 30 41.4% 57.4% 54.6% 
>30 12.4% 16.4% 11.8% 
      
      
Cirrhosis 
no 91.4% 84.7% 90.1% 
0.008 
yes 8.6% 15.3% 9.9% 
      
      
Portal vein embolization  
no 90.3% 85.7% 94.7% 
0.005 
yes 9.7% 14.3% 5.3% 
      
Type of resection minor 48.1% 44.9% 45.4% 0.627 
 major 51.9% 55.1% 54.6%  
 
Type of clamping  
    
 
0.446 
 
 
selective 9.4% 11.5% 7.9%  
 pedicular 71.2% 72.3% 76.3% 
 no 19.4% 16.1% 15.8%  
 
Caval vein clamping 
    
 
0.278 
 
 
no 92.2% 93.3% 96.1% 
 
 
yes 7.8% 6.7% 3.9% 
    
 
Perioperative radiofrequency 
    
 
0.056 
 
 
no 93.3% 96.2% 97.4%  
 yes 6.7% 3.8% 2.6% 
      
 
Associated colorectal resection 
    
 
0.917 
 
 
no 92.5% 92.5% 93.4%  
 yes 7.5% 7.5% 6.6% 
      
 
Associated vascular resection 
    
 
0.227 
 
 
no 97.6% 98.7% 96.7%  
 yes 2.4% 1.3% 3.3% 
      
      
 
    
 
    
 
Table 3. The risk factors for postoperative mortality.  
 
      Univariate   Multivariable 
Parameter    Alive Died     
    n (%) n (%) 
p 
value 
Odds Ratio (95%CI) p value 
Age  (years) 
<60  366 (37.5) 6 (23.1)  
 
0.045 
1.000  - 
60 to 74  465 (47.7) 12 (46.2) 1.468 (0.518-4.154) 0.470 
≥75  144 (14.8) 8 (30.7) 4.751(1.498-15.066) 0.008 
Gender 
male 661 (67.8) 22 (84.6) 
0.069 
    
female 314 (32.2) 4 (15.4)     
BMI  
<25 341 (35) 7 (26.9) 
0.554 
    
25 to 30 495 (50.8) 16 (61.5)     
≥30 139 (14.2) 3 (11,6)     
Cirrhosis 
no 863 (88.5) 18 (69.2) 
0.008 
1.000 -  
yes 112 (11.5) 8 (30.8) 3.314 (1.234-8.900) 0.017 
Preoperative 
chemotherapy 
no 549 (56.3) 22 (84.6) 
0.015 
    
old 63 (6.4) 1 (3.9)     
recent* 363 (37.3) 3 (11.5)     
Preoperative 
arterial 
chemoembolization 
no 932 (95.6) 19 (73.1) 
<0.001 
1.000 -  
yes 43 (4.4) 7 (26.9) 5.487 (1.969-15285) 0.001 
Portal vein 
embolization 
no 871 (89.3) 18 (69.2) 
0.005 
    
yes 104 (10.7) 8 (30.8)     
Type of tumor 
metastases 498 (51.1) 6 (23.1) 
0.015 
    
Primary 
cancer 
329 (33.7) 15 (57.7) 
    
Benign 
tumor 
148 (15.2) 5 (19.2) 
    
Surgical approach 
laparotomy 933 (95.7) 26 (100) 
0.622 
    
laparoscopy 42 (4.3) 0 (0)     
Type of resection 
minor 457 (46.9) 5 (19.2) 
0.005 
    
major 518 (53.1) 21 (80.8)     
Type of clamping  
selective 99 (10.2) 3 (11.5) 
0.76 
    
pedicular 706 (72.2) 20 (77)     
no 170 (17.6) 3 (11.5)     
Caval vein 
clamping 
no 914 (93.7) 20 (76.9) 
0.006 
1.000 -  
yes 61 (6.3) 6 (23.1) 6.103 (2.121-17.514) 0.001 
Associated 
colorectal resection 
no 904 (92.7) 23 (88.5) 
0.433 
    
yes 71 (7.3) 3 (11.5)     
Associated 
vascular resection 
no 955 (97.9) 26 (100) 
1 
    
yes 20 (2.1) 0 (0)     
Intraoperative 
blood  transfusion 
no 762 (78.2) 15 (57.7) 
0.013 
1.000  - 
yes 213 (21.8) 11 (42.3) 2.361 (1.023-5.449) 0.044 
*recent defined chemotherapy performed within 6 months before surgery.
Table 4. The postoperative complications according to the patient age. 
 
                  Age (years)  
  < 60 60 to 74 >75  
  n=372 (%) n=477 (%) (n=152) p value 
       
Postoperative 
complication 
no 242 (65.1) 292 (61.2) 87 (57.2) 
0.216 
yes 130 (34.9) 185 (38.8) 65 (42.8) 
Clavien 
classification 
grade of 
complications 
I 24 (6.4)    24 (5)   13 (8.6) 
0.269 
II   46 (12.4)   84 (17.6)  25 (16.4) 
IIIa 24 (6.4) 29 (6.1) 8 (5.3) 
IIIb 21 (5.6) 20 (4.2) 6 (3.9) 
IVa 8 (2.2) 11 (2.3) 5 (3.3) 
IVb 1 (0.3) 5 (1)     0 (0) 
V 6 (1.6)   12 (25.2) 8 (5.3) 
 
  
Table 5. The type of postoperative complications seen according to patient age 
 Age (years)  
Parameter 
< 60 (n=372) 
n (%) 
60 to 74 (n=477) 
n (%) 
>75 (n=152) 
n (%) p value 
  10 (2.7) 12 (2.5) 7 (4.6) 0.39 
Liver failure     
      
Postoperative ascites 14 (3.8) 25 (5.2) 2 (1.3) 0.10 
      
Biliary leak/fistula 27 (7.3) 45 (9.4) 8 (5.3) 0.21 
      
Postoperative hemorrhage 18 (4.8) 11 (2.3) 8 (5.3) 0.08 
      
Intra-abdominal abscess 24 (6.5) 16 (3.4) 6 (3.9) 0.09 
      
Wound infection 2 (0.5) 5 (1) 2 (1.3) 0.62 
      
Systemic infection 28 (7.5) 40 (8.4) 13 (8.6) 0.88 
      
Pulmonary Complication  20 (5.4) 35 (7.3) 10 (6.6) 0.52 
      
Urinary complication 9 (2.4) 15 (3.1) 4 (2.6) 0.81 
      
Deep venous thrombosis 7 (1.9) 7 (1.5) 1 (0.7) 0.58 
      
Major complications 
 
59 (15.9) 76 (15.9) 
27 (17.8) 
0.09 
Hospital stay (days)† 10.8 ± 7.4 12 ± 9.2 13± 8.2 0.02 
† Mean ± Standard deviation (SD) 
Major complications are defined as Clavien group ≥ III. 
 
Table 6. The risk factors for 1-year mortality. 
      Univariate   Multivariate  
Parameter    Alive Died      
    n (%) n (%) p value 
Odds Ratio 
(95%CI) 
p 
value 
Age (years) 
<60  360  (38) 12  (21.8) 
0.018 
1.000  - 
60 to 74  448  (47.4) 29  (52.7) 1.636 (0.787-3.403) 0.188 
≥75  138  (14.6) 14  (25.5) 2.838 (1.223-6.584) 0.015 
Sex 
male 637  (67.3) 46  (83.6) 
0.012 
    
female 309  (32.7) 9  (16.7)     
BMI  
<25 334  (35.3) 14  (25.5) 
0.239 
    
25 to 30 477  (50.4) 34  (61.8)     
≥30 135  (14.3) 7  (12.7)     
Cirrhosis 
no 841  (88.9) 40  (72.7) 
<0.001 
1.000 - 
yes 105  (11.1) 15  (27.3) 2.628 (1.229-5.620) 0.013 
Preoperative 
chemotherapy 
no 530  (56) 41  (74.6) 
0.026 
    
old 62  (6.6) 2   (3,6)     
Recent* 354  (37.4) 12  (21.8)     
Preoperative arterial 
chemoembolization 
no 
904  
(95.6%) 
47  (85.5) 
0.004 
1.000 -  
yes 42  (4.4) 8  (14.5) 5.487 (1.969-15.285) 0.001 
Portal vein 
embolization 
no 846  (89.4) 43  (78.2) 
0.01 
    
yes 100  (10.6) 12  (21.8)     
Type of tumor 
metastases 489  (51.7) 15  (27.3) 
<0.001 
1.000 - 
Primary cancer 311  (32.9) 33  (60) 2.266 0.026 
Benign tumor 146  (15.4) 7 (22.7) 1.753 0.246 
Surgical approach 
laparotomy 904  (95.7) 55  (100) 
0.110 
    
laparoscopy 42  (4.3) 0  (0)     
Type of resection 
minor 450  (47.6) 12  (11.8) 
<0.001 
1.000  
major 496  (52.4) 43  (78.2) 3.019 (1.516-60.15) 0.002 
Type de clamping  
selective 98  (10.4) 4  (6.3) 
0.608 
    
pedicular 683  (72.2) 43  (78.2)     
no 165  (17.4) 8  (14.5)     
Caval vein clamping 
no 886  (93.7) 48  (87.3) 
0.087 
1,000  
yes 60  (6.3) 7  (22.7) 2.301 0.069 
Associated colorectal 
resection 
no 876  (92.6) 51  (92.7) 
0.616 
    
yes 70  (7.4) 4  (7.3)     
Associated vascular 
resection 
no 927  (98) 54  (98.2) 
0.698 
    
yes 19  (2) 1  (1.8)     
Intraoperative blood  
transfusion 
no 744  (78.6) 33  (60) 
0.001 
1.000  
yes 202  (21.4) 22  (40) 2.078 (1.149-3.759) 0.016 
  
  *recent defined chemotherapy performed within 6 months before surgery 
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